Allergy Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cambridge Allergy Ltd: Camallergy Awarded £1.1 M Funding Under Innovate UK Biomedical Catalyst Award for Novel Peanut Allergy Treatment -Company to provide corporate update at upcoming Global Life Sciences investor conference Cambridge Allergy Ltd ("Camallergy" or "the Company"), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced it has been awarded £1.1M funding under the Innovate UK Biomedical Catalyst Award program administered by Innovate UK, the United Kingdom's research and innovation agency. ...

Share: -Facility to supply drug product for planned Phase 3 clinical trials and early access programme Cambridge Allergy Ltd ("Camallergy" or "the Company"), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced that its manufacturing facility outside of Portsmouth, United Kingdom was approved by the MHRA, the Medicines and Healthcare products Regulatory Agency, to manufacture its proprietary peanut allergy treatment under current Good Manufacturing Practices (cGMP) standards. "This clearance is a pivotal...